ery. As the solution, the university and the hospital issued the foundation a sublicensable license; CFFT has issued five of these sublicenses to date. The drawback is that CFFT has assumed the administrative burden, spending a great deal of time with the business offices of the companies explaining the sublicense terms. Overall, however, the approach has resulted in a win–win solution. CFFT reports annually to the university on what parties are operating under the sublicenses. The university gains recognition that its patent is broadly accepted as valid and receives a nominal fee from CFFT. When well-defined intellectual property is necessary to advance research on a given condition, this approach may be one option to consider.